DSM has made an agreement to purchase Martek Biosciences Corporation for $1,087,000 in cash. The transaction will take place in the first or second quarter of 2011.
“This acquisition is an attractive and logical next step for DSM,” explained the CEO/Chairman of the DSM Managing Board, Mr. Feike Sijbesma. “Martek’s leading position in healthy, natural ingredients and algal technology will add a new growth platform to our Nutrition business. DSM is a unique partner for Martek and, with our strong track record of growing businesses in competitive environments, we believe we can help to lift Martek to the next level.”
DSM has been supplying Martek with the key base material for its arachidonic acid product for a long time. DSM also has complementary intellectual property to the broad range of patents and intellectual property owned by Martek. This will further expand the competitiveness of the products owned by the combined company.
